| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.140 | 16.295 | 21.313 | 50.799 | 59.783 | 76.725 | 145.160 | 78.923 |
| Total Income - EUR | - | - | 3.140 | 16.295 | 22.645 | 55.074 | 61.116 | 76.822 | 146.049 | 79.326 |
| Total Expenses - EUR | - | - | 1.250 | 11.006 | 22.278 | 37.632 | 52.203 | 49.471 | 76.880 | 62.928 |
| Gross Profit/Loss - EUR | - | - | 1.889 | 5.289 | 367 | 17.442 | 8.913 | 27.351 | 69.168 | 16.398 |
| Net Profit/Loss - EUR | - | - | 1.795 | 4.800 | 154 | 16.947 | 8.375 | 26.732 | 67.934 | 14.382 |
| Employees | - | - | 0 | 0 | 1 | 2 | 4 | 2 | 0 | 1 |
Check the financial reports for the company - Sanomed Ange S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 346 | 48.814 | 35.925 | 57.400 | 47.180 | 34.610 | 34.814 |
| Current Assets | - | - | 1.900 | 26.940 | 13.443 | 34.873 | 45.703 | 51.685 | 103.958 | 67.352 |
| Inventories | - | - | 307 | 1.991 | 2.627 | 2.578 | 2.942 | 0 | 0 | 0 |
| Receivables | - | - | 62 | 1.534 | 4.317 | 27.242 | 32.669 | 44.931 | 100.414 | 54.587 |
| Cash | - | - | 1.531 | 23.415 | 6.499 | 5.053 | 10.092 | 6.754 | 3.544 | 12.765 |
| Shareholders Funds | - | - | 1.839 | 6.605 | 6.631 | 23.452 | 31.307 | 49.069 | 76.826 | 53.806 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 61 | 20.681 | 55.626 | 47.346 | 71.797 | 49.796 | 61.742 | 48.360 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sanomed Ange S.r.l.